148 related articles for article (PubMed ID: 28006839)
1. High IKKα expression is associated with reduced time to recurrence and cancer specific survival in oestrogen receptor (ER)-positive breast cancer.
Bennett L; Quinn J; McCall P; Mallon EA; Horgan PG; McMillan DC; Paul A; Edwards J
Int J Cancer; 2017 Apr; 140(7):1633-1644. PubMed ID: 28006839
[TBL] [Abstract][Full Text] [Related]
2. The relationship between members of the canonical NF-κB pathway, components of tumour microenvironment and survival in patients with invasive ductal breast cancer.
Bennett L; Mallon EA; Horgan PG; Paul A; McMillan DC; Edwards J
Oncotarget; 2017 May; 8(20):33002-33013. PubMed ID: 28423692
[TBL] [Abstract][Full Text] [Related]
3. The NF-κB Pathway Promotes Tamoxifen Tolerance and Disease Recurrence in Estrogen Receptor-Positive Breast Cancers.
Kastrati I; Joosten SEP; Semina SE; Alejo LH; Brovkovych SD; Stender JD; Horlings HM; Kok M; Alarid ET; Greene GL; Linn SC; Zwart W; Frasor J
Mol Cancer Res; 2020 Jul; 18(7):1018-1027. PubMed ID: 32245803
[TBL] [Abstract][Full Text] [Related]
4. The relationship between the insulin-like growth factor-1 system and the oestrogen metabolising enzymes in breast cancer tissue and its adjacent non-cancerous tissue.
Chong YM; Colston K; Jiang WG; Sharma AK; Mokbel K
Breast Cancer Res Treat; 2006 Oct; 99(3):275-88. PubMed ID: 16752221
[TBL] [Abstract][Full Text] [Related]
5. Raptor localization predicts prognosis and tamoxifen response in estrogen receptor-positive breast cancer.
Bostner J; Alayev A; Berman AY; Fornander T; Nordenskjöld B; Holz MK; Stål O
Breast Cancer Res Treat; 2018 Feb; 168(1):17-27. PubMed ID: 29128895
[TBL] [Abstract][Full Text] [Related]
6. Non-canonical NF-κB pathway activation predicts outcome in borderline oestrogen receptor positive breast carcinoma.
Rojo F; González-Pérez A; Furriol J; Nicolau MJ; Ferrer J; Burgués O; Sabbaghi M; González-Navarrete I; Cristobal I; Serrano L; Zazo S; Madoz J; Servitja S; Tusquets I; Albanell J; Lluch A; Rovira A; Eroles P
Br J Cancer; 2016 Jul; 115(3):322-31. PubMed ID: 27404455
[TBL] [Abstract][Full Text] [Related]
7. Determining the prognostic significance of IKKα in prostate cancer.
Montes M; MacKenzie L; McAllister MJ; Roseweir A; McCall P; Hatziieremia S; Underwood MA; Boyd M; Paul A; Plevin R; MacKay SP; Edwards J
Prostate; 2020 Oct; 80(14):1188-1202. PubMed ID: 33258506
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of Forkhead box protein A1 (FOXA1) leads to cancer stem cell-like properties in tamoxifen-resistant breast cancer cells through induction of interleukin-6.
Yamaguchi N; Nakayama Y; Yamaguchi N
J Biol Chem; 2017 May; 292(20):8136-8148. PubMed ID: 28270510
[TBL] [Abstract][Full Text] [Related]
9. Tamoxifen-induced ER-alpha-SRC-3 interaction in HER2 positive human breast cancer; a possible mechanism for ER isoform specific recurrence.
Mc Ilroy M; Fleming FJ; Buggy Y; Hill AD; Young LS
Endocr Relat Cancer; 2006 Dec; 13(4):1135-45. PubMed ID: 17158759
[TBL] [Abstract][Full Text] [Related]
10. Decreased expression of Yes-associated protein is associated with outcome in the luminal A breast cancer subgroup and with an impaired tamoxifen response.
Lehn S; Tobin NP; Sims AH; Stål O; Jirström K; Axelson H; Landberg G
BMC Cancer; 2014 Feb; 14():119. PubMed ID: 24559095
[TBL] [Abstract][Full Text] [Related]
11. RERG (Ras-like, oestrogen-regulated, growth-inhibitor) expression in breast cancer: a marker of ER-positive luminal-like subtype.
Habashy HO; Powe DG; Glaab E; Ball G; Spiteri I; Krasnogor N; Garibaldi JM; Rakha EA; Green AR; Caldas C; Ellis IO
Breast Cancer Res Treat; 2011 Jul; 128(2):315-26. PubMed ID: 20697807
[TBL] [Abstract][Full Text] [Related]
12. The relationship between oestrogen receptor-alpha phosphorylation and the tumour microenvironment in patients with primary operable ductal breast cancer.
Cheng KK; Dickson A; Gujam FJ; McMillan DC; Edwards J
Histopathology; 2017 Apr; 70(5):782-797. PubMed ID: 27891654
[TBL] [Abstract][Full Text] [Related]
13. SIRT2: tumour suppressor or tumour promoter in operable breast cancer?
McGlynn LM; Zino S; MacDonald AI; Curle J; Reilly JE; Mohammed ZM; McMillan DC; Mallon E; Payne AP; Edwards J; Shiels PG
Eur J Cancer; 2014 Jan; 50(2):290-301. PubMed ID: 24183459
[TBL] [Abstract][Full Text] [Related]
14. Retinoic acid receptor alpha is associated with tamoxifen resistance in breast cancer.
Johansson HJ; Sanchez BC; Mundt F; Forshed J; Kovacs A; Panizza E; Hultin-Rosenberg L; Lundgren B; Martens U; Máthé G; Yakhini Z; Helou K; Krawiec K; Kanter L; Hjerpe A; Stål O; Linderholm BK; Lehtiö J
Nat Commun; 2013; 4():2175. PubMed ID: 23868472
[TBL] [Abstract][Full Text] [Related]
15. Tamoxifen resistance and metastasis of human breast cancer cells were mediated by the membrane-associated estrogen receptor ER-α36 signaling in vitro.
Gu W; Dong N; Wang P; Shi C; Yang J; Wang J
Cell Biol Toxicol; 2017 Apr; 33(2):183-195. PubMed ID: 27837347
[TBL] [Abstract][Full Text] [Related]
16. Androgen receptor expression predicts beneficial tamoxifen response in oestrogen receptor-α-negative breast cancer.
Hilborn E; Gacic J; Fornander T; Nordenskjöld B; Stål O; Jansson A
Br J Cancer; 2016 Feb; 114(3):248-55. PubMed ID: 26742006
[TBL] [Abstract][Full Text] [Related]
17. Expression of the forkhead transcription factor FOXP1 is associated with that of estrogen receptor-beta in primary invasive breast carcinomas.
Bates GJ; Fox SB; Han C; Launchbury R; Leek RD; Harris AL; Banham AH
Breast Cancer Res Treat; 2008 Oct; 111(3):453-9. PubMed ID: 18026833
[TBL] [Abstract][Full Text] [Related]
18. Homeobox transcription factor muscle segment homeobox 2 (Msx2) correlates with good prognosis in breast cancer patients and induces apoptosis in vitro.
Lanigan F; Gremel G; Hughes R; Brennan DJ; Martin F; Jirström K; Gallagher WM
Breast Cancer Res; 2010; 12(4):R59. PubMed ID: 20682066
[TBL] [Abstract][Full Text] [Related]
19. MiRNA-27a sensitizes breast cancer cells to treatment with Selective Estrogen Receptor Modulators.
Ljepoja B; García-Roman J; Sommer AK; Wagner E; Roidl A
Breast; 2019 Feb; 43():31-38. PubMed ID: 30415143
[TBL] [Abstract][Full Text] [Related]
20. Estrogen receptor-alpha phosphorylation at serine 305, nuclear p21-activated kinase 1 expression, and response to tamoxifen in postmenopausal breast cancer.
Bostner J; Skoog L; Fornander T; Nordenskjöld B; Stål O
Clin Cancer Res; 2010 Mar; 16(5):1624-33. PubMed ID: 20179234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]